News
Filing of market authorization approval
22/02/01

SUSMED has successfully filed market authorization approval about DTx for Insomnia.

Previous
Back to list
Next
Latest Article
2026/05/07
KYORIN and SUSMED Initiate Confirmatory Study Using Digital Therapeutics App Designed for Patients with Tinnitus
2026/01/06
The application for insomnia has been featured in the japan times
2025/11/06
FISCO Analyst Report